A Case of a Long-term Survivor with EGFR Mutation-positive Non-small-cell Lung Cancer After Valve Replacement Under Extracorporeal Circulation and Aggressive Treatments Against Other Cardiovascular Complications During EGFR-tyrosine Kinase Inhibitor Treatment
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.